Arch Therapeutics Inc (ARTH)
1.18
0.00 (0.00%)
USD |
OTCM |
Apr 29, 16:00
Arch Therapeutics Debt to Equity Ratio: -0.746 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.746 |
| September 30, 2023 | -0.7496 |
| June 30, 2023 | -0.3857 |
| March 31, 2023 | -0.3103 |
| December 31, 2022 | -0.6375 |
| September 30, 2022 | -0.8019 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.3985 |
| March 31, 2022 | -0.523 |
| December 31, 2021 | -0.6602 |
| September 30, 2021 | -1.560 |
| June 30, 2021 | 2.599 |
| March 31, 2021 | 0.8658 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.560
Minimum
Sep 2021
2.599
Maximum
Jun 2021
-0.2757
Average
-0.5802
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | 0.0229 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.4243 |
| Asensus Surgical Inc | 0.00 |
| Senseonics Holdings Inc | 1.151 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.822M |
| Total Liabilities (Quarterly) | 11.40M |
| Shareholders Equity (Quarterly) | -9.576M |
| Current Ratio | 0.1592 |
| Net Debt Paydown Yield | -2.20% |